What top creators are saying about Anthropic(ANTH)— Page 2

Identified as a significant liquidity event in the AI sector that is capturing institutional attention.

Identified as a premier AI sector leader and a must-own candidate that is currently staying private longer than previous tech generations.

Strong secondary market demand indicates high institutional appetite despite competition from the SpaceX/Cursor ecosystem.

Overtaken OpenAI in annual recurring revenue and winning the enterprise war through reliability and strategic cloud partnerships.

Valuation questioned relative to the likelihood of a successful multi-trillion dollar IPO.

Gaining a competitive edge over OpenAI in the enterprise sector with Claude Code and a more cost-effective, focused product roadmap.

Acquired Coefficient Bio for $400 million to expand into AI-driven drug R&D and biotech.

Viewed as a better risk-reward profile than OpenAI with a lower secondary valuation and potential October IPO.

Mentioned as a platform player that vertical AI companies seek to resist disruption from through deep client integration.

Expanding into AI-powered drug discovery through the acquisition of Coefficient Bio.

Seeing increased secondary bids but faces broader market skepticism regarding high-valuation AI startups.

Targeted IPO as early as October; represents the cutting edge of LLM software.

Strong competitor to OpenAI with significant valuation growth; potential IPO candidate.

Primary rival to OpenAI in the IPO race; seen as a key alternative for investors looking to capture peak AI market sentiment.

Capturing significant enterprise interest as the 'ethical' alternative to OpenAI with strong commercial momentum.

Preparing for a potential Q4 2026 IPO; demonstrates lower cash burn and faster path to profitability compared to OpenAI.

Currently viewed as the leader in Enterprise/B2B and coding segments with a head start over competitors in these high-margin niches.

Anticipated IPO is identified as a potential trigger for a massive market implosion.

Explosive revenue growth reaching $20 billion annualized.

High-value private firm mentioned in the context of wealth creation happening outside of public markets.

Designated a 'supply chain risk' by the Pentagon due to contract disputes, though still considered a high-growth potential play despite regulatory headwinds.

Shifting to a competitive-first stance; forecasted high revenue growth but faces potential supply chain risks with the DoD.

Faces significant regulatory risk and federal de-platforming due to refusal to allow military use for autonomous actions, despite having a technological lead and $14 billion in revenue.

Preparing a tender at a $350B valuation; high growth in API sales and disruption of legacy systems with COBOL modernization tools.

Represents a focused bet on high-value enterprise AI adoption. Its Claude models are highly regarded by developers, but the company faces significant price pressure from OpenAI.

Viewed as a smaller, up-and-coming competitor to OpenAI that may offer more 'asymmetry' and higher potential returns due to its smaller size and valuation.

Mentioned as a potential M&A target for Apple, but its rumored valuation has reached $170 billion, making it 'basically unobtainable'.

Experiencing explosive valuation growth, underscoring intense investor demand. Strong insider confidence is signaled by past investors' continued participation in a new funding round. This is a pre-IPO opportunity.

Experiencing massive growth and demand, but is throttling user access and likely pricing below cost to capture market share, a venture-funded strategy that creates financial fragility and may not be sustainable.

Experiencing explosive revenue growth, with Annual Recurring Revenue (ARR) growing from $1 billion to $5 billion in months. Its API revenue has reportedly overtaken OpenAI's, signaling it is a top-tier competitor.

A private AI company whose valuation was reportedly bid up to $170 billion by Meta in a 'fearful catch up move,' and is considered less attractively valued than OpenAI.

A high-growth, high-valuation play with a 'world-class' product and strong enterprise strategy, but the 37x sales valuation is considered 'absurd' and high-risk, contingent on maintaining extraordinary growth.

Presented as a top-tier AI player with exceptional growth, quadrupling Annualized Recurring Revenue (ARR) to $4 billion in seven months. The launch of specialized financial tools is a new growth driver.

Mentioned as one of the key foundational AI platforms on which valuable applications like Harvey are built.

Mentioned as a potential AI partner for Apple to power the next generation of its virtual assistant, Siri.